Wertpapierdatensatz · archiviertes Quartal
INBX
Inhibrx Biosciences Inc. · Healthcare · Biotechnology
17Erfasste Halter
+7Δ Inhaber
4.45MGehaltene Aktien
$150.05MGemeldeter Wert
+7Neue Positionen
−0Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +30.0% ·
Aktienfluss +2.7% ·
neue Nettopositionen +20.0%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | +7 | 8.53M | $807.74M | +12 | −4 |
| Q1 2026 | 65 | -3 | 7.61M | $511.38M | +3 | −7 |
| Q4 2025 | 69 | 0 | 8.07M | $637.42M | +2 | −1 |
| Q3 2025 | 17 | +7 | 4.45M | $150.05M | +7 | — |
| Q2 2025 | 7 | 0 | 3.86M | $55.09M | — | — |
| Q1 2025 | 4 | -1 | 2.48M | $34.64M | — | −1 |
| Q4 2024 | 5 | -2 | 2.53M | $38.98M | — | −2 |
| Q3 2024 | 6 | +1 | 2.46M | $38.48M | +2 | −1 |
| Q2 2024 | 5 | — | 2.53M | $35.86M | — | — |
Wer es hält · Q3 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 1.79M | 0.0% | $60.21M | 0.2% | Held | 6 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 684.75K | -6.0% | $23.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 684.75K | -6.0% | $23.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 684.75K | -6.0% | $23.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 684.75K | -6.0% | $23.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 684.75K | -6.0% | $23.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 684.75K | -6.0% | $23.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 684.75K | -6.0% | $23.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 684.75K | -6.0% | $23.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passiv) | 594.92K | -0.6% | $20.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passiv) | 594.92K | -0.6% | $20.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passiv) | 594.92K | -0.6% | $20.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 442.86K | — | $14.92M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 442.86K | — | $14.92M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 442.86K | — | $14.92M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 442.86K | — | $14.92M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 442.86K | — | $14.92M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 442.86K | — | $14.92M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 297.82K | +8.0% | $10.03M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passiv) | 221.92K | -1.8% | $7.48M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passiv) | 221.92K | -1.8% | $7.48M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (passiv) | 203.92K | -0.5% | $6.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 57.19K | Neu | $1.93M | 0.0% | New | 1 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 57.19K | Neu | $1.93M | 0.0% | New | 1 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 39.33K | +0.7% | $1.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 39.33K | +0.7% | $1.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Wellington Management ✦ | 29.76K | Neu | $1.00M | 0.0% | New | 1 | SEC ↗ |
| 28 | Wellington Management ✦ | 29.76K | Neu | $1.00M | 0.0% | New | 1 | SEC ↗ |
| 29 | Wellington Management ✦ | 29.76K | Neu | $1.00M | 0.0% | New | 1 | SEC ↗ |
| 30 | Marshall Wace ✦ | 27.24K | Neu | $917,511 | 0.0% | New | 1 | SEC ↗ |
| 31 | Goldman Sachs Group ✦ | 25.97K | — | $874,535 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 11.55K | Neu | $389,105 | 0.0% | New | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 9.66K | — | $325,282 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 9.66K | — | $325,282 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 9.66K | — | $325,282 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 9.66K | — | $325,282 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Renaissance Technologies ✦ | 8.40K | Neu | $282,912 | 0.0% | New | 1 | SEC ↗ |
| 38 | Arrowstreet Capital ✦ | 6.00K | Neu | $202,181 | 0.0% | New | 1 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 6.00K | Neu | $202,013 | 0.0% | New | 1 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 6.00K | Neu | $202,013 | 0.0% | New | 1 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 6.00K | Neu | $202,013 | 0.0% | New | 1 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 6.00K | Neu | $202,013 | 0.0% | New | 1 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 6.00K | Neu | $202,013 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Citadel Advisors | $1.93M | 0.0% |
| Citadel Advisors | $1.93M | 0.0% |
| Wellington Management | $1.00M | 0.0% |
| Wellington Management | $1.00M | 0.0% |
| Wellington Management | $1.00M | 0.0% |
| Marshall Wace | $917,511 | 0.0% |
| D. E. Shaw & Co. | $389,105 | 0.0% |
| Renaissance Technologies | $282,912 | 0.0% |
| Arrowstreet Capital | $202,181 | 0.0% |
| AQR Capital Management | $202,013 | 0.0% |
| AQR Capital Management | $202,013 | 0.0% |
| AQR Capital Management | $202,013 | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 134 Inhaber, 12.71M Anteile, $853.40M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q3 2025 ·
Methodik ·
Über die API abrufen